Maximilian Schiwek holds a bachelor's degree in Microbiology and Genetics (2021) and a master's degree in Molecular Microbiology, Microbial Ecology and Immunobiology (2024), both from the University of Vienna. For his bachelor's thesis at the Department of Structural and Computational Biology, Vienna BioCenter, he investigated the catalytic activity of the enzyme calcineurin and its inhibition by FATZ-1. For his master's thesis at the Center for Cancer Research, Medical University of Vienna, he characterized the impact of a Kallmann syndrome-associated mutation in the FGF signalling modulator Spry4 on the proliferation, migration and FGF-mediated signalling in osteosarcoma- and glioblastoma-derived cells.
Maximilian joined ICTCT at BOKU University in January 2025 to investigate the impact of 2D versus 3D culture on the functional characteristics of mesenchymal stem cell-derived extracellular vesicles (MSC-EVs). This project is funded by the Austrian Science Fund (FWF) and is conducted in collaboration with the Center for Biomedical Technology at the University for Continuing Education Krems. His main focus is to compare, evaluate, and establish scalable methods in both 2D and 3D systems for the high-throughput production of MSC-EVs.